• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Jan25
Distribution Plan(CST)

Cash dividend 0.2 CNY

Jan21
Distribution Plan(CST)

Cash dividend 0.2 CNY

Distribution Plan(CST)

Cash dividend 0.2 CNY

View More

Event Tracking

Dec13
CITIC International and J.P. Morgan Maintain Buy Rating on Zijin Mining
05:18
2025 National Medical Insurance Drug Directory Update, Hengrui and Eli Lilly are Major Winners
03:47
Dec12
Hengrui Medicine's Subsidiary Receives Clinical Trial Approval Notice for RSS0343 Tablets from NMPA
11:57
HRS9531 Injection Approved for Clinical Trials by Huahai Medicine's Subsidiary
11:53
BlackRock reduces its long position in Zijin Mining to 7.61%
09:29
Morgan Stanley Reduces Its Holding in Hengrui Medicine
09:22